S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

NYSE:CLB - Core Laboratories Stock Price, Forecast & News

$45.53
+1.53 (+3.48 %)
(As of 12/12/2019 04:00 PM ET)
Today's Range
$44.24
Now: $45.53
$45.69
50-Day Range
$42.99
MA: $45.49
$48.96
52-Week Range
$36.61
Now: $45.53
$75.63
Volume648,722 shs
Average Volume634,813 shs
Market Capitalization$2.02 billion
P/E Ratio19.97
Dividend Yield5.00%
Beta1.98
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. Read More…

Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
CUSIPN/A
Phone31-20-420-3191

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$700.85 million
Cash Flow$2.87 per share
Book Value$3.64 per share

Profitability

Net Income$79.52 million

Miscellaneous

Employees4,700
Market Cap$2.02 billion
Next Earnings Date1/29/2020 (Estimated)
OptionableOptionable

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.


Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Tuesday, October 8th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.55 per share on Tuesday, November 19th. This represents a $2.20 dividend on an annualized basis and a yield of 4.83%. The ex-dividend date of this dividend is Thursday, October 17th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) issued its quarterly earnings results on Wednesday, October, 23rd. The oil and gas company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.49 by $0.01. The oil and gas company earned $173.20 million during the quarter, compared to the consensus estimate of $171.38 million. Core Laboratories had a net margin of 14.68% and a return on equity of 45.63%. The business's revenue was down 4.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.64 earnings per share. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its fourth quarter earnings guidance on Wednesday, October, 23rd. The company provided earnings per share guidance of $0.44-0.45 for the period, compared to the Thomson Reuters consensus estimate of $0.46. The company issued revenue guidance of $161-163 million, compared to the consensus revenue estimate of $167.98 million.

What price target have analysts set for CLB?

10 brokers have issued 1-year price objectives for Core Laboratories' shares. Their forecasts range from $46.00 to $77.00. On average, they expect Core Laboratories' stock price to reach $62.50 in the next year. This suggests a possible upside of 37.3% from the stock's current price. View Analyst Price Targets for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Has Core Laboratories been receiving favorable news coverage?

Press coverage about CLB stock has been trending extremely negative on Thursday, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Core Laboratories earned a news sentiment score of -4.0 on InfoTrie's scale. They also gave news headlines about the oil and gas company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an effect on the company's share price in the near future. View News Stories for Core Laboratories.

Are investors shorting Core Laboratories?

Core Laboratories saw a decline in short interest in the month of November. As of November 29th, there was short interest totalling 3,330,000 shares, a decline of 10.0% from the November 14th total of 3,700,000 shares. Based on an average daily trading volume, of 655,100 shares, the short-interest ratio is presently 5.1 days. Approximately 7.6% of the company's shares are sold short. View Core Laboratories' Current Options Chain.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Starbucks (SBUX), Micron Technology (MU), Baidu (BIDU), NIC (EGOV), Athabasca Oil (ATH) and AT&T (T).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
  • Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (10.63%), Select Equity Group L.P. (3.48%), Fisher Asset Management LLC (2.41%), Manning & Napier Group LLC (1.80%), Disciplined Growth Investors Inc. MN (1.68%) and State Street Corp (1.67%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Millennium Management LLC, Russell Investments Group Ltd., Boston Trust Walden Corp, Shelter Mutual Insurance Co, Oppenheimer Asset Management Inc., Howland Capital Management LLC and Marble Harbor Investment Counsel LLC. View Insider Buying and Selling for Core Laboratories.

Which major investors are buying Core Laboratories stock?

CLB stock was bought by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Select Equity Group L.P., Teacher Retirement System of Texas, Stephens Investment Management Group LLC, Manning & Napier Group LLC, Douglas Lane & Associates LLC, Kornitzer Capital Management Inc. KS and State of New Jersey Common Pension Fund D. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett and Jan Willem Sodderland. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $45.53.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $2.02 billion and generates $700.85 million in revenue each year. The oil and gas company earns $79.52 million in net income (profit) each year or $2.28 on an earnings per share basis. Core Laboratories employs 4,700 workers across the globe.View Additional Information About Core Laboratories.

What is Core Laboratories' official website?

The official website for Core Laboratories is http://www.corelab.com/.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]


MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  430 (Vote Outperform)
Underperform Votes:  569 (Vote Underperform)
Total Votes:  999
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Featured Article: Quick Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel